Metrics

The numbers behind Doximity, Inc.: as-reported financial statements and company metrics for FY2022–FY2026, traced to the source filings, opened with the share-price history those statements have to justify. Every linked figure opens the exact page of the filing it was printed on, with the statement row highlighted. Amounts in US$ thousands unless noted.

Reading notes: All figures are as printed in Doximity's SEC filings, in thousands of US dollars (per-share and percentage rows excepted). Fiscal year ends March 31. FY2020 and FY2021 income-statement, EPS and operating-cash-flow figures in the Long-Term Record are the comparative columns of the FY2022 Form 10-K (Doximity's IPO 10-K); FY2020/FY2021 balance-sheet detail is not shown as the corpus 10-Ks print only two balance-sheet years. Income-statement line labels drift across years: the income-tax line is 'Provision for (benefit from) income taxes' through FY2024 and 'Provision for income taxes' thereafter; the restructuring line first appears in FY2024 ('Restructuring', 7,936), is 'Restructuring and impairment charges' in FY2025 (2,304) and nil in FY2026. Rows use the most descriptive label; each citation quote is verbatim to its own filing. Cash-flow investing/financing subtotal labels also drift ('Net cash used in …' vs 'Net cash provided by (used in) …'); quotes are verbatim per year.

Share Price — Full Available History — 5 Years

The stock closed at $21.77 on Jul 10, 2026 — down 59% over the window shown (-16.2% a year), trading between $18.01 and $102.02. At that close the stock trades at 22× FY2026 diluted EPS as reported below.

Source: market price feed, weekly closes, sampled from 1,266 source observations, Jun 2021–Jul 2026. Price return only, excludes dividends.

FY2026 at a Glance

Source: FY2026 consolidated statements [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.

Revenue by Type

Revenue by Type	FY2022	FY2023	FY2024	FY2025	FY2026
Subscription	319,298	389,739	450,071	543,770	608,413
Other	24,250	29,313	25,351	26,629	36,450
Total revenue	343,548	419,052	475,422	570,399	644,863
Total revenue growth, derived	—	+22.0%	+13.5%	+20.0%	+13.1%

Source: Revenue disaggregation footnote (Note 3 — Revenue), Form 10-K [5] [6] [7] [8]. Click any linked figure to open the filing page with the row highlighted.

Income Statement

Source: Consolidated Statements of Operations [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.

Columns marked E are consensus analyst estimates shown alongside reported results for direct comparison; they are not company guidance.

Estimate source: Yahoo Finance analyst consensus, as of 2026-07-12. Estimate figures link to the consensus source, not to filing pages.

Balance Sheet

Source: Consolidated Balance Sheets [9] [10] [11] [12]. Click any linked figure to open the filing page with the row highlighted.

Cash Flow

Source: Consolidated Statements of Cash Flows [13] [14] [15] [16]. Click any linked figure to open the filing page with the row highlighted.

Profitability Cash Generation (non-GAAP)

Profitability Cash Generation (non-GAAP)	FY2022	FY2023	FY2024	FY2025	FY2026
Adjusted EBITDA	150,272	183,983	230,460	313,829	357,816
Adjusted EBITDA margin	44.0%	44.0%	48.0%	55.0%	55.0%
Net income margin	45.0%	27.0%	31.0%	39.0%	30.0%
Free cash flow	120,878	173,418	178,295	266,740	317,495

Source: company filings [17] [18] [19] [20]. Click any linked figure to open the filing page with the row highlighted.

Network Reach Retention

Network Reach Retention	FY2022	FY2023	FY2024	FY2025	FY2026
Net revenue retention rate	157.0%	117.0%	114.0%	119.0%	109.0%
Registered members (period end)	2,000,000	2,000,000	2,000,000	2,000,000	3,000,000
Registered members as % of U.S. physicians	80.0%	80.0%	80.0%	80.0%	85.0%

Source: company filings [21] [22] [23] [24]. Click any linked figure to open the filing page with the row highlighted.

Stock-Based Compensation by Function

Stock-Based Compensation by Function	FY2022	FY2023	FY2024	FY2025	FY2026
Cost of revenue	4,979	9,634	9,479	11,001	11,680
Research and development	7,065	12,583	11,978	19,394	46,159
Sales and marketing	8,108	16,939	16,857	26,323	39,397
General and administrative	11,290	8,678	9,116	15,668	24,391
Total stock-based compensation expense	31,442	47,834	51,076	72,386	121,627

Source: company filings [25] [26] [27] [28]. Click any linked figure to open the filing page with the row highlighted.

Long-Term Record

Fiscal year	Total revenue	Income from operations	Net income	Diluted net income per share	Net cash provided by operating activities
FY2020	116,388	22,163	29,737	0.13	26,199
FY2021	206,897	53,303	50,210	0.23	82,973
FY2022	343,548	113,536	154,783	0.70	126,575
FY2023	419,052	125,108	112,818	0.53	179,602
FY2024	475,422	163,878	147,582	0.72	184,096
FY2025	570,399	227,800	223,185	1.11	273,265
FY2026	644,863	214,920	196,051	0.98	326,458

Source: consolidated statements across filings; older years from the standardized feed [13] [1] [14] [2]. Click any linked figure to open the filing page with the row highlighted.

Operating KPIs

KPI	FY2022	FY2023	FY2024	FY2025	FY2026
Net revenue retention rate	157%	117%	114%	119%	109%
Customers with at least $500,000 of revenue	—	—	98	116	125
Customers with at least $100,000 of revenue	265	294	296	—	—

Source: company-reported operating metrics [21] [23] [29] [30]. Click any linked figure to open the filing page with the row highlighted.

Analyst Consensus

Estimate source: Yahoo Finance analyst consensus, as of 2026-07-12. Estimate figures link to the consensus source, not to filing pages.

Traceability

350 of 354 figures on this page (99%) link to the filing page where they are printed — click a linked figure to open the source PDF at that page with the row highlighted. Unlinked figures come from standardized data feeds or pre-filing years.

• All figures are as printed in Doximity's SEC filings, in thousands of US dollars (per-share and percentage rows excepted). Fiscal year ends March 31.

• FY2020 and FY2021 income-statement, EPS and operating-cash-flow figures in the Long-Term Record are the comparative columns of the FY2022 Form 10-K (Doximity's IPO 10-K); FY2020/FY2021 balance-sheet detail is not shown as the corpus 10-Ks print only two balance-sheet years.

• Income-statement line labels drift across years: the income-tax line is 'Provision for (benefit from) income taxes' through FY2024 and 'Provision for income taxes' thereafter; the restructuring line first appears in FY2024 ('Restructuring', 7,936), is 'Restructuring and impairment charges' in FY2025 (2,304) and nil in FY2026. Rows use the most descriptive label; each citation quote is verbatim to its own filing.

• Cash-flow investing/financing subtotal labels also drift ('Net cash used in …' vs 'Net cash provided by (used in) …'); quotes are verbatim per year.

• Doximity carries no debt; the balance sheet shows no borrowings. The company's real reinvestment runs through 'Internal-use software development costs' (shown in the cash-flow statement) rather than purchases of property and equipment, which are negligible.

• The ≥$100,000-revenue customer metric was disclosed through the FY2024 10-K and discontinued thereafter; the ≥$500,000 metric was introduced in the FY2024 10-K. Net revenue retention is disclosed every year.

• Quarterly cash flow: single quarters are derived from the printed year-to-date statements (see the statement note); every derived value reconciles exactly to two printed year-to-date figures and was cross-checked against the quarterly data feed.

• Quarterly Q4 income columns (Q4 FY25, Q4 FY26) are derived as full-year (10-K) minus nine-month year-to-date (Q3 10-Q); diluted EPS is left blank for Q4 because per-share amounts are not additive.

• 1 figure(s) differed between the data feed and the filing; the filing value is shown (see the run's metrics/metrics_tab.json for the audit trail).